4
Changes in Ownership
Immunome Inc. Filed Acc 0001831215-26-000002
CHIEF BUSINESS OFFICER sold 1,092 shares at $25.00 ($27,300)
- CHIEF BUSINESS OFFICER acquired 1,092 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horn Kinney CHIEF BUSINESS OFFICER | 2026-07-07 | Option exercise 10b5-1 | +1,092 | $12.92 | $14,109 | 1,092 | D: show line 1 in the form |
| Horn Kinney CHIEF BUSINESS OFFICER | 2026-07-07 | Sale 10b5-1 | −1,092 | $25.00 | $27,300 | 0 | D: show line 2 in the form |
| Open-market sales · 1,092 sh · avg $25.00 · $27,300 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Horn Kinney CHIEF BUSINESS OFFICER | 2026-07-07 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,092 | 128,908 | D: show line 3 in the form |
Loading xslF345X06/form4-07092026_090734.xml…